2024-12-10 スウォンジー大学
<関連情報>
- https://www.swansea.ac.uk/press-office/news-events/news/2024/12/swansea-expert-contributes-to-landmark-guide-on-exercise-and-automated-insulin-delivery-systems.php
- https://link.springer.com/article/10.1007/s00125-024-06308-z
1型糖尿病における身体活動と運動時の自動インスリン投与:欧州糖尿病学会(EASD)と国際小児・思春期糖尿病学会(ISPAD)の見解声明 The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Othmar Moser,Dessi P. Zaharieva,Peter Adolfsson,Tadej Battelino,Richard M. Bracken,Bruce A. Buckingham,Thomas Danne,Elizabeth A. Davis,Klemen Dovč,Gregory P. Forlenza,Pieter Gillard,Sabine E. Hofer,Roman Hovorka,Peter G. Jacobs,Julia K. Mader,Chantal Mathieu,Kirsten Nørgaard,Nick S. Oliver,David N. O’Neal,John Pemberton,Rémi Rabasa-Lhoret,Jennifer L. Sherr,Harald Sourij,Martin Tauschmann,… Michael C. Riddell
Diabetologia Published:10 December 2024
DOI:https://doi.org/10.1007/s00125-024-06308-z
Graphical Abstract
Abstract
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
